Bloomberg
Vaccine Envy Hits Japan Markets as Investors Eye Suga’s New Deal
(Bloomberg) — Japan won praise during the pandemic for staying open while other developed economies locked down — helping lift stocks to three-decade highs. But as the country now struggles with its inoculation program, a case of vaccine envy is breaking out.The Topix is down 1% in the past month, compared with gains of 5.2% in the S&P 500 Index and 2.6% by the FTSE 100 in London, where photos of revelers at re-opened pubs this week contrast with reports from Tokyo, where hours at bars and restaurants